ADVISORS

Lou Dietz, M.S.

Lou has extensive experience in imaging systems, optical detection, and microfluidics for life science applications, and has developed numerous successful products for the medical diagnostic and bioanalytical research markets. He is currently the Vice-President of Engineering at Biodesy. As a consultant, he has designed FDA-cleared products for digital pathology and point-of-care diagnostic testing. He has also held senior engineering management roles in several companies, such as On-Q-ity (formerly CELLective DX), Nanoplex Technologies, and SurroMed, where he has managed teams developing microfluidic devices and instrumentation for analyzing circulating tumor cells in blood samples, automated manufacturing of microparticles and nanoparticles for multiplexed immunoassays, and automated laser-scanning cytometry systems for biomarker discovery and clinical diagnostics. The author or co-author of federal grants totaling $13 million, he holds 15 U.S. patents covering optical instrumentation, nanoparticle manufacturing techniques, and electronic circuitry for communications systems. He received his B.S. and M.S. in Electrical Engineering from Stanford University.

BACK

 

Khushroo Gandhi, Ph.D.

Khushroo has extensive experience in product development and microfluidics device fabrication in various substrates such as silicon, glass and polymers.  He is currently the Vice-President of Product Development and Manufacturing at GBP Scientific, where he is leading the product development and manufacturing activities for both instrument and consumables. Previously, he was at Caliper, (a Perkin Elmer company) where he held multiple leadership roles, including Site Manager and Director of Process Development and Engineering. He was responsible for all operations of microfluidic consumables manufacturing site with over $20M in annual revenue, led large multi-disciplinary projects such as improving the Quality Management system, obtaining ISO13485 registration, transferring manufacturing technology among sites, and directed scale-up efforts and manufacturing of various microfluidic chip and reagent product lines.

BACK

 

Bill Hyun, M.S., Ph.D.

Bill is the Director of the Laboratory for Advanced Cytometry at the University of California, San Francisco (UCSF). He leverages over 25 years of translational and clinical research experience into founder, investor and advisor roles for several biotechnology companies and life science investment groups. At UCSF, he helped build the world’s largest academic cytometry facility and continues to design and build next generation cell sorters, commercial flow cytometers and confocal microscopes.

BACK

 

Anne Kopf-Sill, Ph.D.

Anne has been working in product development in the life science tools and medical diagnostic space for 30 years. She is the inventor or co-inventor on more than 50 patents in the areas of microfluidics and diagnostics. Her expertise is in product development and marketing for new technologies in life science and diagnostic markets. Most of the products that she has developed are multidisciplinary, involving the development of a consumable, reagents, instrument, and software. Anne currently has a position at the Stanford Office of Technology Transfer, where she evaluates Stanford professors’ and grad students’ inventions for commercial potential, gets patents drafted, finds companies to license the technology and executes the licenses. Prior to this position, she was at Tecan Systems overseeing the R&D for a new microfluidic platform using electrowetting. Previous positions included being President of CellPoint Diagnostics developing technology for detecting and analyzing circulating tumor cells in cancer patients. Before that she was Sr. VP of Product Development & Operations at NuGEN making reagent kits to amplify and study nucleic acids. She was one of the first employees at Caliper Technologies and built and ran their microfluidics group for many years. Early in her career, she developed and marketed a point-of-care diagnostic product to analyze blood chemistries from a single drop of blood while at Abaxis and developed research instruments at Molecular Devices.

BACK